248
Participants
Start Date
March 27, 2022
Primary Completion Date
December 6, 2024
Study Completion Date
February 17, 2025
Argipressin
Infusion of Argipressin 0.8 U/ml, 0.056 ml/kg/h will be started as soon as the central line is placed, and continued until the end of surgery in the treatment arm.
Placebo
Infusion of Normal Saline 0.056 ml/kg/h will be started as soon as the central line is placed, and continued until the end of surgery in the placebo arm.
Sahlgrenska University Hospital, Gothenburg
Kristina Svennerholm
OTHER